Table 5 Comparison between group I (control group) and group II (case group) regarding levels of hemoglobin, AST, ALT, albumin, total bilirubin, INR, platelets, and creatinine 8 weeks after treatment

Hemoglobin (gm/dl)

Mean ± SD

12.53 ± 1.35

9.43 ± 1.75

9.763

0.001

Range

9.8–15.5

6.4–13

AST (U/L)

Normal

50 (100%)

46 (100%)

0.930

0.335

High

0 (0%)

0 (0%)

ALT (U/L)

Normal

49 (98%)

46 (100%)

0.930

0.335

High

1(2%)

0(0%)

Albumin (gm/dl)

Mean ± SD

4.18 ± 0.39

3.97 ± 0.54

2.202

0.030

Range

2.6–5.1

2–5.4

Bilirubin (mg/dl)

Mean ± SD

0.90 ± 0.42

0.62 ± 0.24

3.848

0.001

Range

0.3–2.08

0.1–1.39

INR

Mean ± SD

1.11 ± 0.16

1.10 ± 0.13

0.618

0.538

Range

0.95–2

0.67–1.4

Platelets (10³/mm³)

Mean ± SD

234.44 ± 65.96

225.95 ± 68.82

0.610

0.543

Range

135–439

105–400

Creatinine (mg/dl)

Median (IQR)

0.9 (0.8–1)

7 (5.9–9.1)

− 8.310

0.001

Range

0.6–1.2

3.5 –13.8